The firm's assay measures the concentration of the wild type and mutant alleles of hFE protein at three different mutation sites from a person's blood sample.
Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.
In Nature this week: genome sequences of two giant tortoises, genome assemblies and annotations for two allotetraploid cotton species, and more.
The company, established as a merger between A*STAR MedTech spin-off MiRXES and venture capital firm Venturecraft, has developed a blood test for early-stage stomach cancer.
New research suggests that the physicochemical changes to DNA in a cancer-related methylation landscape can alter a DNA molecule's affinity for gold substrates.
Researchers have harnessed how epigenetic reprogramming alters the genome's physicochemical properties to develop a cancer test, the Guardian reports.
Stat News looks into the rapid growth of China's Pharma Valley.
Researchers used genomic and transcriptomic data of isolates from seven Southeast Asian countries to find resistance-relevant pathways and expression quantitative trait loci.
The Southern University of Science and Technology denies that He Jiankui, the controversial gene-editing researcher, has been detained, the South China Morning Post reports.
In PNAS this week: Takayasu arteritis risk loci, gene expression-based subgroups of B-cell precursor acute lymphoblastic leukemia, and more.
In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.
The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.
People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.
MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.